9 FDA recalls mention Rizatriptan. The most recent are listed below.
Recalls are matched by product description. A recall usually affects specific lots, not every package of Rizatriptan.
Reason CGMP Deviations: detection of N-nitroso-dimethyl-rizatriptan impurity, above the FDA recommended acceptable intake limit.
Reason CGMP Deviations: detection of N-nitroso-dimethyl-rizatriptan impurity, above the FDA recommended acceptable intake limit.
Reason CGMP Deviations: N-Nitroso Desmethyl Rizatriptan Impurity results that are above the FDA acceptable limit.
Reason CGMP Deviations: N-Nitroso Desmethyl Rizatriptan Impurity results that are above the FDA acceptable limit.
Reason CGMP Deviations: N-Nitroso Desmethyl Rizatriptan Impurity results that are above the FDA acceptable limit.
Reason CGMP Deviations: N-Nitroso Desmethyl Rizatriptan Impurity results that are above the FDA acceptable limit.
Reason Out-of-specification test results obtained in Organic Impurities test during analysis of controlled samples.
Reason Out-of-specification test results obtained in Organic Impurities test during analysis of controlled samples.
Reason Out-of-specification test results obtained in Organic Impurities test during analysis of controlled samples.
Tell us which medications you take. If the FDA recalls one, we email you - in plain English, with what to do. Free.